NCT00668889

CompletedPhase 3

Dermacyd Tina Gel Tangerina Mix - Photo Evaluation

Sanofi Source

Compare

Other study identifiers

Sponsor study identifier

LACAC_L_03737

Study Type

interventional

Actual enrollment (reported)

25

Locations

1 country

Sites

1

Timeline

Study Start

November 2007

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

January 2008

Actual (reported)

Study Completion

Not reported

Date not reported

Brief Summary

The purpose of this study is to prove the absence of photo irritation and photo sensitivity potential of the product Dermacyd Tina Gel Tangerina Mix.

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 25 participants
Study completion date: Not reported
Date not reported
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
November 2007
Date type not reported
This date has not been verified as actual or estimated.
Primary Completion
January 2008
Actual (reported)
First Submitted
April 23, 2008
Actual (reported)
First Posted
April 29, 2008
Actual (reported)

Last Updated: January 29, 2009
Status Verified: January 2009
Last Update Submitted: January 28, 2009

Conditions

Healthy

Keywords

Hygiene

Outcome Measures

Primary Outcomes (1)

The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale. The sensibility will be evaluated according to the skin type.
5 weeks

Interventions

Lactic acid (Dermacid)Drug

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 60 Years

Sexfemale

Healthy VolunteersYes

Age GroupsAdult (18-64)

You may qualify if:

Phototype Skin II and III
Integral skin test in the region

You may not qualify if:

Sponsors & Collaborators

Sanofi
Industrylead

Study Sites (1)

Sanofi-aventis administrative office

São Paulo, São Paulo, Brazil

MeSH Terms

Interventions

Lactic Acid

Intervention Hierarchy (Ancestors)

LactatesHydroxy AcidsCarboxylic AcidsOrganic Chemicals

Study Officials

Jaderson Lima
Sanofi-aventis administrative office Brazil
STUDY DIRECTOR

Enrollment

25 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: phase 3
Allocation: NON RANDOMIZED
Masking: NONE
Purpose: SUPPORTIVE CARE
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY

Study Record Dates

First Submitted

April 23, 2008

First Posted

April 29, 2008

Study Start

November 2007

Date type not reported

This date has not been verified as actual or estimated.

NCT00668577

Dermatological Evaluation of Topic Compatibility - Dermacyd Breeze

Phase 3Completed

NCT00668460

Dermatological Evaluation of Topic Compatibility-Dermacyd Delicata Pocket BR

Phase 3Completed

NCT00663273

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower

Phase 3Completed

NCT00663325

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower

Phase 3Completed

NCT00668668

Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Sweet Flower

Phase 3Completed

NCT00687037

Safety Oral Mucosa Evaluation - Acceptability With Odontological Follow up - Cepacol Canela Power

Phase 3Completed

Lactation or gestation
Use of Antiinflammatory and/or immunosuppression drugs 15 days before the selection
Diseases which can cause immunity decrease, such as HIV, diabetes
Use of drug photosensitizer
History of sensitivity or irritation for topic products
Active cutaneous disease which can change the study results
History or photodermatosis active
Family or personal antecedent of cutaneous photoinduced neoplasias
Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and keratoses actinium
Intense solar exposure in the study area
Use of new drugs or cosmetics during the study
The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Contact the study team to confirm eligibility.

Primary Completion

January 2008

Actual (reported)

Last Updated

January 29, 2009

Record last verified: 2009-01

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00668889
Data provider: ClinicalTrials.gov
Source updated: 2009-01-29
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:38:34 UTC

Locations

BR(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

Primary Completion

First Submitted

First Posted

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

You may not qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Interventions

Intervention Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations